These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7680311)

  • 21. Anti-human factor IX monoclonal antibodies specific for calcium ion-induced conformations.
    Sugo T; Mizuguchi J; Kamikubo Y; Matsuda M
    Thromb Res; 1990 Jun; 58(6):603-14. PubMed ID: 2385830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural transitions in bovine factor X associated with metal binding and zymogen activation. Studies using conformation-specific antibodies.
    Keyt B; Furie BC; Furie B
    J Biol Chem; 1982 Aug; 257(15):8687-95. PubMed ID: 6178736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfer of specific endothelial cell-binding properties from the procoagulant protein human factor IX into the anticoagulant protein human protein C.
    Geng JP; Christiansen WT; Plow EF; Castellino FJ
    Biochemistry; 1995 Jul; 34(26):8449-57. PubMed ID: 7541242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX.
    Persson KE; Knobe KE; Stenflo J
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1039-44. PubMed ID: 11527405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays.
    Poort SR; van der Linden IK; Krommenhoek-van Es C; Briët E; Bertina RM
    Thromb Haemost; 1986 Feb; 55(1):122-8. PubMed ID: 3704999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of the metal-induced conformational transition of bovine prothrombin.
    Tai MM; Furie BC; Furie B
    J Biol Chem; 1984 Apr; 259(7):4162-8. PubMed ID: 6706997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysine 5 and phenylalanine 9 of the factor IX omega-loop interact with phosphatidylserine in a membrane-mimetic environment.
    Grant MA; Baikeev RF; Gilbert GE; Rigby AC
    Biochemistry; 2004 Dec; 43(49):15367-78. PubMed ID: 15581349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
    Atoda H; Yoshida N; Ishikawa M; Morita T
    Eur J Biochem; 1994 Sep; 224(2):703-8. PubMed ID: 7925387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structurally and functionally distinct Ca2+ binding sites in the gamma-carboxyglutamic acid-containing domain of factor VIIa.
    Persson E; Petersen LC
    Eur J Biochem; 1995 Nov; 234(1):293-300. PubMed ID: 8529655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex.
    Andrews RK; Harris SJ; McNally T; Berndt MC
    Biochemistry; 1998 Jan; 37(2):638-47. PubMed ID: 9425086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interactions of factors X and IX with phospholipid.
    Bloom JW
    Thromb Res; 1989 May; 54(4):261-8. PubMed ID: 2763266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro mutagenesis study of two critical glutamic acids in the calcium binding loop of the factor IX heavy chain.
    Hamaguchi N; Stafford D
    Thromb Haemost; 1994 Dec; 72(6):856-61. PubMed ID: 7740454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphipathic helices support function of blood coagulation factor IXa.
    Blostein MD; Rigby AC; Furie BC; Furie B; Gilbert GE
    Biochemistry; 2000 Oct; 39(39):12000-6. PubMed ID: 11009614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of factor IX antibodies by radioimmunoassay: effect of calcium on antibody-factor IX interaction.
    Lewis RM; Reisner HM; Chung KS; Roberts HR
    Blood; 1980 Oct; 56(4):608-14. PubMed ID: 6158351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the catalytic domain of factor IX that are related to the subclass hemophilia Bm.
    Hamaguchi N; Roberts H; Stafford DW
    Biochemistry; 1993 Jun; 32(25):6324-9. PubMed ID: 8518277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C2A domain of synaptotagmin-like protein 3 (Slp3) is an atypical calcium-dependent phospholipid-binding machine: comparison with the C2A domain of synaptotagmin I.
    Fukuda M
    Biochem J; 2002 Sep; 366(Pt 2):681-7. PubMed ID: 12049610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
    Bray GL; Weinmann AF; Thompson AR
    J Lab Clin Med; 1986 Mar; 107(3):269-78. PubMed ID: 3485164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrostatic interactions during activation of coagulation factor IX via the tissue factor pathway: effect of univalent salts.
    McGee MP; Teuschler H; Liang J
    Biochim Biophys Acta; 1999 Feb; 1453(2):239-53. PubMed ID: 10036322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa.
    Jones ME; Griffith MJ; Monroe DM; Roberts HR; Lentz BR
    Biochemistry; 1985 Dec; 24(27):8064-9. PubMed ID: 3879187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor.
    Komiyama Y; Pedersen AH; Kisiel W
    Biochemistry; 1990 Oct; 29(40):9418-25. PubMed ID: 2248955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.